Global Cerebrovascular Disease Market Research Report 2023

Report ID: 1993913 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Carotid Endarterectomy
        1.2.3 Carotid Angioplasty Or Carotid Artery Stenting
        1.2.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
    1.3 Market by Application
        1.3.1 Global Cerebrovascular Disease Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Academic & Research Institutes
        1.3.3 Pharmaceutical & Biotechnology Companies
        1.3.4 Hospitals & Diagnostic Centers
        1.3.5 Contract Research Organizations
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Cerebrovascular Disease Market Perspective (2018-2029)
    2.2 Cerebrovascular Disease Growth Trends by Region
        2.2.1 Global Cerebrovascular Disease Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Cerebrovascular Disease Historic Market Size by Region (2018-2023)
        2.2.3 Cerebrovascular Disease Forecasted Market Size by Region (2024-2029)
    2.3 Cerebrovascular Disease Market Dynamics
        2.3.1 Cerebrovascular Disease Industry Trends
        2.3.2 Cerebrovascular Disease Market Drivers
        2.3.3 Cerebrovascular Disease Market Challenges
        2.3.4 Cerebrovascular Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cerebrovascular Disease Players by Revenue
        3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2018-2023)
        3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2018-2023)
    3.2 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
    3.4 Global Cerebrovascular Disease Market Concentration Ratio
        3.4.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2022
    3.5 Cerebrovascular Disease Key Players Head office and Area Served
    3.6 Key Players Cerebrovascular Disease Product Solution and Service
    3.7 Date of Enter into Cerebrovascular Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cerebrovascular Disease Breakdown Data by Type
    4.1 Global Cerebrovascular Disease Historic Market Size by Type (2018-2023)
    4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2024-2029)
5 Cerebrovascular Disease Breakdown Data by Application
    5.1 Global Cerebrovascular Disease Historic Market Size by Application (2018-2023)
    5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Cerebrovascular Disease Market Size (2018-2029)
    6.2 North America Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Cerebrovascular Disease Market Size by Country (2018-2023)
    6.4 North America Cerebrovascular Disease Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Cerebrovascular Disease Market Size (2018-2029)
    7.2 Europe Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Cerebrovascular Disease Market Size by Country (2018-2023)
    7.4 Europe Cerebrovascular Disease Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cerebrovascular Disease Market Size (2018-2029)
    8.2 Asia-Pacific Cerebrovascular Disease Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Cerebrovascular Disease Market Size by Region (2018-2023)
    8.4 Asia-Pacific Cerebrovascular Disease Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Cerebrovascular Disease Market Size (2018-2029)
    9.2 Latin America Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Cerebrovascular Disease Market Size by Country (2018-2023)
    9.4 Latin America Cerebrovascular Disease Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cerebrovascular Disease Market Size (2018-2029)
    10.2 Middle East & Africa Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Cerebrovascular Disease Market Size by Country (2018-2023)
    10.4 Middle East & Africa Cerebrovascular Disease Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Detail
        11.1.2 Johnson & Johnson Business Overview
        11.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
        11.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2018-2023)
        11.1.5 Johnson & Johnson Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Cerebrovascular Disease Introduction
        11.2.4 Amgen Revenue in Cerebrovascular Disease Business (2018-2023)
        11.2.5 Amgen Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
        11.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2018-2023)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Sanofi-Aventis
        11.4.1 Sanofi-Aventis Company Detail
        11.4.2 Sanofi-Aventis Business Overview
        11.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
        11.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2018-2023)
        11.4.5 Sanofi-Aventis Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Cerebrovascular Disease Introduction
        11.5.4 Merck Revenue in Cerebrovascular Disease Business (2018-2023)
        11.5.5 Merck Recent Development
    11.6 Sangamo BioSciences
        11.6.1 Sangamo BioSciences Company Detail
        11.6.2 Sangamo BioSciences Business Overview
        11.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
        11.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2018-2023)
        11.6.5 Sangamo BioSciences Recent Development
    11.7 Aldagen
        11.7.1 Aldagen Company Detail
        11.7.2 Aldagen Business Overview
        11.7.3 Aldagen Cerebrovascular Disease Introduction
        11.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2018-2023)
        11.7.5 Aldagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Carotid Endarterectomy
    Table 3. Key Players of Carotid Angioplasty Or Carotid Artery Stenting
    Table 4. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
    Table 5. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Cerebrovascular Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Cerebrovascular Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Cerebrovascular Disease Market Share by Region (2018-2023)
    Table 9. Global Cerebrovascular Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Cerebrovascular Disease Market Share by Region (2024-2029)
    Table 11. Cerebrovascular Disease Market Trends
    Table 12. Cerebrovascular Disease Market Drivers
    Table 13. Cerebrovascular Disease Market Challenges
    Table 14. Cerebrovascular Disease Market Restraints
    Table 15. Global Cerebrovascular Disease Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Cerebrovascular Disease Market Share by Players (2018-2023)
    Table 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2022)
    Table 18. Ranking of Global Top Cerebrovascular Disease Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Cerebrovascular Disease Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cerebrovascular Disease Product Solution and Service
    Table 22. Date of Enter into Cerebrovascular Disease Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cerebrovascular Disease Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Cerebrovascular Disease Revenue Market Share by Type (2018-2023)
    Table 26. Global Cerebrovascular Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Cerebrovascular Disease Revenue Market Share by Type (2024-2029)
    Table 28. Global Cerebrovascular Disease Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Cerebrovascular Disease Revenue Market Share by Application (2018-2023)
    Table 30. Global Cerebrovascular Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Cerebrovascular Disease Revenue Market Share by Application (2024-2029)
    Table 32. North America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Cerebrovascular Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Cerebrovascular Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Cerebrovascular Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Cerebrovascular Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Cerebrovascular Disease Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Cerebrovascular Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Cerebrovascular Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Johnson & Johnson Company Detail
    Table 48. Johnson & Johnson Business Overview
    Table 49. Johnson & Johnson Cerebrovascular Disease Product
    Table 50. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 51. Johnson & Johnson Recent Development
    Table 52. Amgen Company Detail
    Table 53. Amgen Business Overview
    Table 54. Amgen Cerebrovascular Disease Product
    Table 55. Amgen Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 56. Amgen Recent Development
    Table 57. GlaxoSmithKline Company Detail
    Table 58. GlaxoSmithKline Business Overview
    Table 59. GlaxoSmithKline Cerebrovascular Disease Product
    Table 60. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 61. GlaxoSmithKline Recent Development
    Table 62. Sanofi-Aventis Company Detail
    Table 63. Sanofi-Aventis Business Overview
    Table 64. Sanofi-Aventis Cerebrovascular Disease Product
    Table 65. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 66. Sanofi-Aventis Recent Development
    Table 67. Merck Company Detail
    Table 68. Merck Business Overview
    Table 69. Merck Cerebrovascular Disease Product
    Table 70. Merck Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. Sangamo BioSciences Company Detail
    Table 73. Sangamo BioSciences Business Overview
    Table 74. Sangamo BioSciences Cerebrovascular Disease Product
    Table 75. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 76. Sangamo BioSciences Recent Development
    Table 77. Aldagen Company Detail
    Table 78. Aldagen Business Overview
    Table 79. Aldagen Cerebrovascular Disease Product
    Table 80. Aldagen Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
    Table 81. Aldagen Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cerebrovascular Disease Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Cerebrovascular Disease Market Share by Type: 2022 VS 2029
    Figure 3. Carotid Endarterectomy Features
    Figure 4. Carotid Angioplasty Or Carotid Artery Stenting Features
    Figure 5. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features
    Figure 6. Global Cerebrovascular Disease Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Cerebrovascular Disease Market Share by Application: 2022 VS 2029
    Figure 8. Academic & Research Institutes Case Studies
    Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 10. Hospitals & Diagnostic Centers Case Studies
    Figure 11. Contract Research Organizations Case Studies
    Figure 12. Others Case Studies
    Figure 13. Cerebrovascular Disease Report Years Considered
    Figure 14. Global Cerebrovascular Disease Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Cerebrovascular Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Cerebrovascular Disease Market Share by Region: 2022 VS 2029
    Figure 17. Global Cerebrovascular Disease Market Share by Players in 2022
    Figure 18. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2022
    Figure 20. North America Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Cerebrovascular Disease Market Share by Country (2018-2029)
    Figure 22. United States Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Cerebrovascular Disease Market Share by Country (2018-2029)
    Figure 26. Germany Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Cerebrovascular Disease Market Share by Region (2018-2029)
    Figure 34. China Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Cerebrovascular Disease Market Share by Country (2018-2029)
    Figure 42. Mexico Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Cerebrovascular Disease Market Share by Country (2018-2029)
    Figure 46. Turkey Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Cerebrovascular Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 49. Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 50. GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 51. Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 52. Merck Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 53. Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 54. Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
Frequently Asked Questions
Cerebrovascular Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cerebrovascular Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cerebrovascular Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cerium

This report aims to provide a comprehensive presentation of the global market for Cerium, with bo ... Read More